AGÕæÈ˹ٷ½

STOCK TITAN

Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

VAUGHAN, Ontario--(BUSINESS WIRE)--

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its second-quarter financial results on Wednesday, July 30, 2025. The company will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the section of the Bausch + Lomb website prior to the start of the call.

Bausch + Lomb will hold an investor day on Thursday, Nov. 13, 2025, where the company will provide a business update and highlight its innovative product pipeline. Additional details will follow closer to the event.

Second-Quarter Conference Call Details

Date:

Wednesday, July 30, 2025

Ìý

Time:

8 a.m. ET

Ìý

Webcast:

Ìý

Participant Event Dial-in:

+1 (888) 506-0062 (North America)

+1 (973) 528-0011 (International)

Ìý

Participant Access Code:

155159

Ìý

Replay Dial-in:

+1 (877) 481-4010 (North America)

+1 (919) 882-2331 (International)

Ìý

Replay Passcode:

51714 (replay available until August 13, 2025)

About Bausch + Lomb
Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world � from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,500 employees and a presence in approximately 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit and connect with us on , , , and .

© 2025 Bausch + Lomb.

Media Contact:

Chris Clark

[email protected]

(848) 360-1100



Investor Contact:

George Gadkowski

[email protected]

(877) 354-3705 (toll free)

Source: Bausch + Lomb Corporation

Bausch + Lomb Corporation

NYSE:BLCO

BLCO Rankings

BLCO Latest News

BLCO Latest SEC Filings

BLCO Stock Data

4.82B
41.83M
88.13%
11.09%
1.16%
Medical Instruments & Supplies
Ophthalmic Goods
Canada
VAUGHAN